Authors:
Xu, JS
Rodriguez, D
Petitclerc, E
Kim, JJ
Hangai, M
Moon, YS
Davis, GE
Brooks, PC
Citation: Js. Xu et al., Proteolytic exposure of a cryptic site within collagen type IV is requiredfor angiogenesis and tumor growth in vivo (vol 154, pg 1069, 2001), J CELL BIOL, 155(5), 2001, pp. 859-859
Authors:
Xu, JS
Rodriguez, D
Petitclerc, E
Kim, JJ
Hangai, M
Yuen, SM
Davis, GE
Brooks, PC
Citation: Js. Xu et al., Proteolytic exposure of a cryptic site within collagen type IV is requiredfor angiogenesis and tumor growth in vivo, J CELL BIOL, 154(5), 2001, pp. 1069-1079
Citation: Pc. Brooks et al., Identification of some DNA damage-inducible genes of Mycobacterium tuberculosis: Apparent lack of correlation with LexA binding, J BACT, 183(15), 2001, pp. 4459-4467
Citation: Js. Xu et al., Generation of monoclonal antibodies to cryptic collagen sites by using subtractive immunization, HYBRIDOMA, 19(5), 2000, pp. 375-385
Authors:
Henriet, P
Zhong, ZD
Brooks, PC
Weinberg, KI
DeClerck, YA
Citation: P. Henriet et al., Contact with fibrillar collagen inhibits melanoma cell proliferation by up-regulating p27(KIP1), P NAS US, 97(18), 2000, pp. 10026-10031
Authors:
Petitclerc, E
Boutaud, A
Prestayko, A
Xu, JS
Sado, Y
Ninomiya, Y
Sarras, MP
Hudson, BG
Brooks, PC
Citation: E. Petitclerc et al., New functions for non-collagenous domains of human collagen type IV - Novel integrin ligands inhibiting angiogenesis and tumor growth in vivo, J BIOL CHEM, 275(11), 2000, pp. 8051-8061
Citation: Je. Testa et al., Eukaryotic expression cloning with an antimetastatic monoclonal antibody identifies a tetraspanin (PETA-3/CD151) as an effector of human tumor cell migration and metastasis, CANCER RES, 59(15), 1999, pp. 3812-3820
Authors:
Petitclerc, E
Stromblad, S
von Schalscha, TL
Mitjans, F
Piulats, J
Montgomery, AMP
Cheresh, DA
Brooks, PC
Citation: E. Petitclerc et al., Integrin alpha(V)beta(3) promotes M21 melanoma growth in human skin by regulating tumor cell survival, CANCER RES, 59(11), 1999, pp. 2724-2730